Chr. Olesen & Co. A/S Revenue and Competitors
Estimated Revenue & Valuation
- Chr. Olesen & Co. A/S's estimated annual revenue is currently $20.7M per year.
- Chr. Olesen & Co. A/S's estimated revenue per employee is $201,000
Employee Data
- Chr. Olesen & Co. A/S has 103 Employees.
- Chr. Olesen & Co. A/S grew their employee count by 26% last year.
Chr. Olesen & Co. A/S Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.7M | 123 | -25% | N/A | N/A |
#2 | $4.6M | 23 | N/A | $114.3M | N/A |
#3 | $33.8M | 168 | -11% | $204.6M | N/A |
#4 | $21.1M | 105 | -7% | N/A | N/A |
#5 | $10.5M | 52 | -7% | N/A | N/A |
#6 | $90.9M | 400 | -8% | $508.6M | N/A |
#7 | $7.2M | 36 | -5% | N/A | N/A |
#8 | $113.4M | 564 | -9% | N/A | N/A |
#9 | $28.9M | 144 | 0% | N/A | N/A |
#10 | $13.5M | 67 | -3% | N/A | N/A |
What Is Chr. Olesen & Co. A/S?
Chr. Olesen is a distribution company. We strive to be perceived as the best link between manufactures and customers in distributing high-quality ingredients to the feed, food and pharmaceutical industries all over the world. Reliability is the quality assurance of everything we do.
keywords:N/A
N/A
Total Funding
103
Number of Employees
$20.7M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Chr. Olesen & Co. A/S News
Desde 1º de Janeiro de 2022 a cadeia da produção de proteína animal no Brasil e América Latina conta com uma nova empresa, a NHU/Chr. Olesen...
New Market Report on Denmark Vermouth Market, Estimating for Years 2019-2026, and Prominent Players are, Carlsberg Group Chr. Olesen ...
The global portable medical devices market which was represented a CAGR of approximately +9% in the midst of the estimate time span of ...
... of Spepharm B.V., Bionpharma Inc., CoreRx, Inc., Leon Nanodrugs GmbH, Pharmaceutics International, Inc. and Chr. Olesen Synthesis A/S
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $27.8M | 103 | 4% | N/A |
#2 | $25.2M | 103 | 12% | N/A |
#3 | $33.8M | 103 | 13% | N/A |
#4 | N/A | 103 | 11% | N/A |
#5 | $27.8M | 103 | 1% | N/A |
